Slot allocation for DCP/NP marketing authorisation applications
DCP with Iceland as RMS and national applications
IMA acts as Reference Member State in DC-procedures. IMA is ambitious to actively participate in assessment of marketing authorisation applications. Slot requests are also applicable for national procedures.
A slot is a time interval in which it is possible to submit an application for marketing authorisation of a medicinal product within a DCP/NP to the Icelandic Medicines Agency with Iceland as the Reference Member State and to the agencies of the Concerned Member States.
Please click on an available time slot and fill in a request form. Please note that the table shows the current status of slots and submitting a request does not garantee a slot. All requests will be responded to.
| Month and year | DCP/NP applications |
|---|---|
| July, 2026 | |
| August, 2026 | |
| September, 2026 | |
| October, 2026 | |
| November, 2026 | |
| December, 2026 | |
| January, 2027 | |
| February, 2027 | |
| March, 2027 | |
| April, 2027 | |
| May, 2027 | |
| June, 2027 |